PRIORIX

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug PRIORIX contains one active pharmaceutical ingredient (API):

1 Measles, live attenuated
Read about Measles, live attenuated

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BD52 Measles, combinations with mumps and rubella, live attenuated J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BD Measles vaccines
Discover more medicines within J07BD52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510605701155312, 510618090060307
Country: CA Health Products and Food Branch Identifier(s): 02239208
Country: EE Ravimiamet Identifier(s): 1039340, 1066137, 1611548, 1611559, 1611560, 1611571, 1611582, 1611593, 1611605, 1611616, 1611627, 1611638
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 62314
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 390034, 405597
Country: FR Base de données publique des médicaments Identifier(s): 61896473
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 349254
Country: HK Department of Health Drug Office Identifier(s): 43861
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4146
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1017850, 1017851, 1017852, 1017853, 1024863, 1024865, 1070891, 1070892, 1070893, 1070894, 1070949, 1070950, 1070951, 1070952, 1070953, 1070954, 1070955, 1070956, 1088535
Country: MT Medicines Authority Identifier(s): MA170/01301, MA170/01302, PI1438/02001A, PI770/16501A
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 8110
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100224251
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W58947005, W58947006, W58947007, W58947008, W58947009, W58947010, W58947011, W58947012, W58947013, W58947014, W58947015, W58947016, W58947017, W58947018, W58947019, W58947020, W58947021, W58947022, W58947023, W58947024
Country: SG Health Sciences Authority Identifier(s): 10822P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 7063111
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699522964215, 8699522964222, 8699522964239, 8699522964246, 8699522967469
Country: ZA Health Products Regulatory Authority Identifier(s): 33/30.1/0346

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.